| 000 | 03661naaaa2200913uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/57786 | ||
| 005 | 20220220095428.0 | ||
| 020 | _abooks978-3-03921-502-7 | ||
| 020 | _a9783039215010 | ||
| 020 | _a9783039215027 | ||
| 024 | 7 |
_a10.3390/books978-3-03921-502-7 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aKawakami, Kohsaku _4auth |
|
| 245 | 1 | 0 | _aRecent Progress in Solid Dispersion Technology |
| 260 |
_bMDPI - Multidisciplinary Digital Publishing Institute _c2019 |
||
| 300 | _a1 electronic resource (204 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aAmorphous solid dispersion (ASD) is a powerful formulation technology to improve oral absorption of poorly soluble drugs. Despite their being in existence for more than half a century, controlling ASD performance is still regarded as difficult because of ASD’s natural non-equilibrium. However, recent significant advances in ASD knowledge and technology may enable a much broader use of ASD technology. This Special Issue, which includes 3 reviews and 6 original articles, focuses on recent progresses in ASD technology in hopes of helping to accelerate developmental studies in the pharmaceutical industry. In striving for a deep understanding of ASD non-equilibrium behavior, the Special issue also delves into and makes progress in the theory of soft-matter dynamics. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by-nc-nd/4.0/ _2cc _4https://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aEnglish | ||
| 653 | _athermodynamic modeling | ||
| 653 | _amolecular dynamics simulation | ||
| 653 | _apoorly soluble drugs | ||
| 653 | _aamorphous solid dispersions | ||
| 653 | _adissolution enhancement | ||
| 653 | _acrystallization tendency | ||
| 653 | _acontinuous processing | ||
| 653 | _astability | ||
| 653 | _amilling | ||
| 653 | _agranulation | ||
| 653 | _athermal analysis | ||
| 653 | _aamorphous | ||
| 653 | _aball milling | ||
| 653 | _apharmaceutical glass | ||
| 653 | _adissolution | ||
| 653 | _arebamipide | ||
| 653 | _apoloxamer | ||
| 653 | _aclassification | ||
| 653 | _apolyelectrolytes | ||
| 653 | _aamorphisation | ||
| 653 | _aself-assembly | ||
| 653 | _adissolution rate | ||
| 653 | _amiscibility | ||
| 653 | _abioavailability | ||
| 653 | _asolubility | ||
| 653 | _aevaporation | ||
| 653 | _amesoporous | ||
| 653 | _apolyelectrolyte excipient matrix | ||
| 653 | _apolymer | ||
| 653 | _abicaludamide | ||
| 653 | _aphase diagram | ||
| 653 | _aWeibull dissolution model | ||
| 653 | _aspectroscopic techniques | ||
| 653 | _aanticancer drugs | ||
| 653 | _amanufacturing methods | ||
| 653 | _anucleation | ||
| 653 | _amolecular complex | ||
| 653 | _ananoaggregates | ||
| 653 | _aenrofloxacin | ||
| 653 | _aaccelerated stability test | ||
| 653 | _asolubility enhancement | ||
| 653 | _aamorphous solid dispersion | ||
| 653 | _atadalafil | ||
| 653 | _aprocess development | ||
| 653 | _aamorphous polymeric salt | ||
| 653 | _aWood’s apparatus | ||
| 653 | _ahot melt extrusion | ||
| 653 | _asolid dispersions | ||
| 653 | _aintrinsic dissolution rate | ||
| 653 | _asolid dispersion | ||
| 653 | _ainteraction | ||
| 653 | _acrystallization | ||
| 653 | _aspray drying | ||
| 653 | _acharacterization | ||
| 653 | _aciprofloxacin | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/1607 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/57786 _70 _zDOAB: description of the publication |
| 999 |
_c79821 _d79821 |
||